Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that on March 5, 2026, it purchased 299,445 ordinary shares as part of its $250 million share repurchase program, with the volume-weighted average price paid per share being 1,230.08 pence. The company intends to cancel these repurchased shares, and as of the announcement, holds 12,833,233 shares in treasury, with 220,559,289 ordinary shares in issue. Since February 26, 2026, Hikma has bought back a total of 1,327,164 shares for £16.9 million.

Disclaimer*

UK 100

Latest directors dealings